Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sameet Chavan of Angel Broking is of the view that one may buy Kesoram Industries with a target of Rs 161.
Ruchit Jain of Angel Broking is of the view that one may buy India Cements with a target of Rs 205.
The midcap Index which was again the outperformer, up 1.29 percent led by Jain Irrigation Systems and Jaiprakash Associates while Bajaj Auto, ICICI Lombard General Insurance Company, MphasiS and Vedanta were some of few stocks that hit 52-week high on the NSE.
Vijay Chopra of enochventures.com is of the view that one may buy NMDC with a target of Rs 130.
The proposed rights issue would be the third from IHCL in the last 10 years, the first two being in 2008 and 2014 for equity & non-convertible debentures, and fully-convertible debentures respectively.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Cholamandalam Investment and can sell India Cements and NMDC.
Sun Pharma, Tech Mahindra, and Indian Hotels, among others are being tracked by investors today.
Vijay Chopra of enochventures.com is of the view that Indian Hotels Company may slip to Rs 115-116.
Ashwani Gujral of ashwanigujral.com suggests buying Century Enka, Tata Coffee and Indian Hotels.
Gaurav Ratnaparkhi of Sharekhan is of the view that one may sell IRB Infrastructure Future with a target of Rs 180.50.
Ruchit Jain of Angel Broking advises buying Tata Global Beverage with a target of Rs 127.
In an interview to CNBC-TV18, Kunj Bansal of Centrum Wealth Management shared his readings and outlook on specific stocks and sectors.
Bank of America Merrill Lynch maintains buy on Lupin with regulatory overhang over valuations should recede post Goa Establishment Inspection Report (EIR). Goa plant accounts for over 50 percent of current supplies to US. It believes the stock should re-rate driven by near-term catalysts and due to faster ramp-up in Gavis portfolio.
Sameet Chavan of Angel Broking is of the view that one may buy Karur Vysya Bank with a target of Rs 534.
Vijay Chopra of Enoch Ventures is of the view that one can buy Everest Kanto Cylinder with a target of Rs 42 and Sterlite Tech with a target of Rs 112.
Rakesh Bansal of RK Global is of the view that one may buy Apollo Tyres with a target of Rs 248.
Morgan Stanley believes that the inflexion point is reached already in the industry. Expanding occupancy numbers can lead to a further rise in pricing in second half of FY17, the note says.
Goldman Sachs reiterates buy on Maruti with target revised to Rs 5774 from Rs 4923 per share. It has raises FY17-18 EPS by 3.5 percent to 4.4 percent on the back of a weaker yen. Moderation is expected in marketing spend post 61 percent surge in FY16 led by Nexa.
Accoring to Sudarshan Sukhani of s2analytics.com, one can buy Indian Hotels and expects higher levels in Balrampur Chini.
In an interview to CNBC-TV18, Mayuresh Joshi of Angel Broking shared his readings and outlook on specific stocks and sector.
Citi has initiated coverage with a buy rating and target of Rs 300 per share. It says that the company has large market opportunities with a special nomination status for government orders and well placed for large order flows in future.
JP Morgan says with both of these asset sales, Indian Hotels' net debt will reduce from Rs 4700 crore as of March 2016 to Rs 3500 crore on a pro-forma basis. The brokerage firm is overweight on the stock stating that these assets were not contributing to earnings and were a drag on the balance sheet and earnings.
The brokerage firm says that the increase in target price reflects scenario value increases of 30-83 percent driven by estimate changes and sale of Taj Boston and higher bull case probability of 30 percent. The company is planning to sell the Taj Boston hotel for at least USD 125 million.
Sahil Kapoor of Edelweiss Broking recommends buying Indian Hotels and Kotak Mahindra Bank and advises selling HCL Tech on rise.